Close  

European Medicines Agency recommends licensing Ebola vaccine

/ 05:15 PM October 20, 2019
Ebola

This undated file image made available by the Centers for Disease Control (CDC) shows the Ebola virus. AP

LONDON — The European Medicines Agency has recommended that the world’s first Ebola vaccine be approved, after it was administered to hundreds of thousands of people in Africa.

The agency on Friday described licensing the vaccine as “an important step toward relieving the burden of this deadly disease.”

ADVERTISEMENT

The Ebola vaccine was originally developed in Canada and is now marketed by Merck as Ervebo. More than 270,000 people in Africa have received it as officials try to stop Congo’s ongoing outbreak.

A second vaccine made by Johnson & Johnson, which is not yet licensed, will soon be used in parts of Congo where Ebola is not actively spreading.

FEATURED STORIES

Also Friday, the World Health Organization is convening a meeting to consider whether the epidemic in Congo should still be designated a global emergency. IB/JB

RELATED STORIES:

Second Ebola vaccine to be used in DR Congo next month

Ebola survivors at higher risk of dying, even after recovery

Filipinos in Congo advised to remain cautious amid ebola outbreak

ADVERTISEMENT
TOPICS: Africa, Congo, ebola, Ebola Virus, Europe, Medical research, vaccines
Read Next
LATEST STORIES
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

For feedback, complaints, or inquiries, contact us.
entertainment

Epy’s advice to guys who are ‘torpe’

November 16, 2019 12:30 AM

entertainment

Alec Baldwin’s wife mourns miscarriage

November 16, 2019 12:25 AM

entertainment

Love shines through in GMA Network’s Christmas Station ID

November 16, 2019 12:20 AM



© Copyright 1997-2019 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.